Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease(914 views) De Rosa A, Pappata S, Pellegrino T, De Leva MF, Maddaluno G, Fiumara G, Carotenuto R, Petretta M, Filla A, De Michele G, Cuocolo A
Keywords: 123i-Metaiodobenzylguanidine, Cardiac Sympathetic Function, Spinocerebellar Ataxia Type 2, (3 Iodobenzyl) Guanidine I 123, Diagnostic Agent, Adult, Article, Autonomic Dysfunction, Clinical Article, Comparative Study, Controlled Study, Diagnostic Accuracy, Drug Uptake, Female, Heart Function, Heart Scintiscanning, Heart To Mediastinum Ratio, Human, Myocardial Washout Rate, Parkinson Disease, Radiological Parameters, Scoring System, Spinocerebellar Degeneration, Adrenergic System, Heart Muscle, Innervation, Metabolism, Middle Aged, Pathophysiology, Transport At The Cellular Level, Young Adult, 3-Iodobenzylguanidine, Biological Transport, Sympathetic Nervous System, 3-Iodobenzylguanidine Diagnostic Use Metabolism, Heart Innervation Radionuclide Imaging, Myocardium Metabolism, Parkinson Disease Metabolism Radionuclide Imaging, Spinocerebellar Ataxias Metabolism Radionuclide Imaging, Sympathetic Nervous System Physiopathology Radionuclide Imaging, (3 Iodobenzyl)guanidine I 123,
Affiliations: *** IBB - CNR ***
Department of Neurosciences and Reproductive and Odontostomatologic Sciences, University Federico II, Naples, Italy.
Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy
Department of Translational Medical Sciences, University Federico II, Naples, Italy
SDN Foundation, Institute of Diagnostic and Nuclear Development, Naples, Italy
Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy
References: Not available.
Reduced Cardiac 123i-Metaiodobenzylguanidine Uptake In Patients With Spinocerebellar Ataxia Type 2: A Comparative Study With Parkinson'S Disease